Outcomes of 55 men who had prophylactic RALPs for suspicion of unproven prostate cancer

Over the years, we have been asked several times whether there is a role for any type of  immediate treatment in men with a high level of concern for their risk of prostate cancer — despite a negative finding on prostate biopsy. … READ MORE …

The newly available, urine-based ExoDx Prostate(IntelliScore) test

Back in April this year we reported on the publication of an article in JAMA Oncology that gave information about the development of a new test for risk of clinically significant prostate cancer — a test that could be conducted using a simple urine sample. … READ MORE …

Vasectomy and risk for prostate cancer (all over again)

As long-term readers will be aware, this is a topic that comes up over and over again … about every couple of years … READ MORE …

Co-morbidity, outcome, all-cause survival, biochemical recurrence, and additional treatment

So we have all heard the commonly used phrase that men with diagnosed with prostate cancer are “more likely to die with prostate cancer than of it” — and there is certainly truth to this generalization. … READ MORE …

Risk for hospitalization after surgery or radiation therapy for localized prostate cancer

According to a newly published article in BJU International, there was little to no major difference in the risks for hospitalization within 1 year after first-line treatment among relatively healthy, Medicare-eligible men with localized prostate cancer treated by either radical surgery or radiation therapy. … READ MORE …

PCA3, mpMRI, targeted biopsies, and risk for diagnosis of prostate cancer

The degree to which the PCA3 test is a useful tool in assessment of risk for clinically significant prostate cancer prior to biopsy has never, really, been entirely clear. … READ MORE …

Obesity and risk for diagnosis with prostate cancer

A new report from the International Agency Research on Cancer (IARC) Handbook Working Group has concluded that there is a definitive link between “body fatness”  and increased risk for diagnosis with 13 different types of cancer — but prostate cancer is not on that list. … READ MORE …